Evidence map›Paper›PMID 23896580›Full record

ArticleHuman vaccines & immunotherapeutics2013

Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging.

Stefan P Petkov, Frank Heuts, Olga A Krotova, Athina Kilpelainen, Gunnel Engström, Elizaveta S Starodubova, Maria G Isaguliants

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Advances in Immunocompetent Mouse and Rat Models.Cold Spring Harbor perspectives in medicine · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Stefan P PetkovDepartment of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden.
Frank HeutsDepartment of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden.
Olga A KrotovaDepartment of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden; WA Engelhardt Institute of Molecular Biology; Russian Academy of Sciences; Moscow, Russia; DI Ivanovsky Institute of Virology; Ministry of Health of the Russian Federation; Moscow, Russia.
Athina KilpelainenDepartment of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden.
Gunnel EngströmDepartment of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden.
Elizaveta S StarodubovaDepartment of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden; WA Engelhardt Institute of Molecular Biology; Russian Academy of Sciences; Moscow, Russia.
Maria G IsaguliantsDepartment of Microbiology; Tumor and Cell Biology; Karolinska Institutet; Stockholm, Sweden; DI Ivanovsky Institute of Virology; Ministry of Health of the Russian Federation; Moscow, Russia.
Karolinska Institutet · SEEngelhardt Institute of Molecular Biology · RUMinistry of Health of the Russian Federation · RURussian Academy of Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of DNA vaccines is highly dependent on the methods used for their delivery and the choice of delivery sites/targets for gene injection, pointing at the necessity of a strict control over the gene delivery process. Here, we have investigated the effect of the injection site on gene expression and immunogenicity in BALB/c mice, using as a model a weak gene immunogen, DNA encoding firefly luciferase (Luc) delivered by superficial or deep injection with subsequent electroporation (EP). Immunization was assessed by monitoring the in vivo expression of luciferase by 2D- and 3D-bioluminescence imaging (BLI) and by the end-point immunoassays. Anti-Luc antibodies were assessed by ELISA, and T-cell response by IFN-γ and IL-2 FluoroSpot in which mouse splenocytes were stimulated with Luc or a peptide representing its immunodominant CD8+ T-cell epitope GFQSMYTFV. Monitoring of immunization by BLI identified EP parameters supporting the highest Luc gene uptake and expression. Superficial injection of Luc DNA followed by optimal EP led to a low level Luc expression in the mouse skin, and triggered a CD8+ T-cell response characterized by the peptide-specific secretion of IFN-γ and IL-2, but no specific antibodies. Intramuscular gene delivery resulted in a several-fold higher Luc expression and anti-Luc antibody, but induced low IL-2 and virtually no specific IFN-γ. Photon flux from the sites of Luc gene injection was inversely proportional to the immune response against GFQSMYTFV (p<0.05). Thus, BLI permitted to control the accuracy of gene delivery and transfection with respect to the injection site as well as the parameters of electroporation. Further, it confirmed the critical role of the site of DNA administration for the type and magnitude of the vaccine-specific immune response. This argues for the use of luminescent reporters in the preclinical gene vaccine tests to monitor both gene delivery and the immune response development in live animals.

Indexed as

Luminescent MeasurementsOptical ImagingAnimalsAntibodiesEnzyme-Linked Immunosorbent AssayFemaleGenes, ReporterImmunizationImmunoassayInsect ProteinsInterferon-gammaInterleukin-2Luciferases, FireflyMiceMice, Inbred BALB CT-LymphocytesAntibodiesInsect ProteinsInterferon-gammaInterleukin-2Luciferases, FireflyVaccines, DNAbioluminescencedeliveryDNAelectroporationimmune responseimmunizationluciferaseroute

Identifiers

PMID23896580
PMCPMC3906409
OpenAlexW2042164600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.